Aridis Pharmaceuticals, Inc. (ARDS)

OTCMKTS: ARDS · Delayed Price · USD

0.0650

+0.0020 (3.17%)

Apr 25, 2024, 3:07 PM EDT - Market closed

Aridis Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016
Net Income	-30.75	-42.28	-21.92	-28.99	-22.11	-24.66	-8.42
Depreciation & Amortization	0.49	0.44	0.34	0.34	0.28	0.06	0.02
Share-Based Compensation	1.48	2.25	2.13	2.01	0	1.61	0.86
Other Operating Activities	-0.34	16.66	-1.02	18.48	-2.45	5.43	1.45
Operating Cash Flow	-29.13	-22.94	-20.48	-8.16	-24.27	-17.56	-6.09
Capital Expenditures	-0.08	-0.53	-0.37	-0.17	-0.68	-0.7	-0.02
Acquisitions	0	0	0	0	-1	0	0
Change in Investments	-	-	-	-	-1	-	-
Other Investing Activities	-	-	-	-	1	-	-
Investing Cash Flow	-0.08	-0.53	-0.37	-0.17	-1.68	-0.7	-0.02
Common Stock Issued	12.61	29.72	7.95	4.96	25.08	0	0
Other Financing Activities	2.17	5.01	0.73	0.04	0.01	21.06	25.51
Financing Cash Flow	14.78	34.72	8.68	4.99	25.09	21.06	25.51
Net Cash Flow	-14.43	11.25	-12.17	-3.34	-0.86	2.81	19.4
Free Cash Flow	-29.21	-23.47	-20.84	-8.33	-24.95	-18.26	-6.11
Free Cash Flow Margin	-	-	-2084.30%	-815.36%	-904.90%	-2122.67%	-269.11%
Free Cash Flow Per Share	-1.56	-1.91	-2.27	-0.99	-7.93	-2.31	-0.77

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.